Residency, Dentistry Pediatric
Lutheran Medical Center
Bengali, Chinese (Mandarin), English, Farsi (Persian), Indian (Hindi), Spanish
Burow L, Attaie AB. Changing How We Care: Innovating the Dental Care Experience for Underserved Communities in New York City. Touchpoint: The Journal of Service Design 2012 January; 3(3).
Attaie A. Access to care: unresolved challenges and call for solutions. Mouth: Journal of the American Student Dental Association 2002;(Winter): 28.
Bikhazi PH, Roeder E, Attaie A, Lalwani AK. Familial paragangliomas: the emerging impact of molecular genetics on evaluation and management. American Journal of Otology 1999 September;: 639-643.
Lalwani AK, Luxford WM, Mhatre AN, Attaie A, Wilcox ER, Castelein CM. A new locus for nonsyndromic hereditary hearing impariment, DFNA17, maps to chromosome 22 and represents a gene for cochleosaccular degeneration [letter]. American Journal of Human Genetics 1999 January;: 318-323.
Lalwani AK, Attaie A, Randolph FT, Deshmukh D, Wang C, Mhatre A, Wilcox E. Point mutation in the MITF gene causing Waardenburg syndrome type II in a three-generation Indian family. American Journal of Medical Genetics 1998 December;: 406-409.
Attaie A, Kim E, Wilcox ER, Lalwani AK. A splice-site mutation affecting the paired box of PAX3 in a three generation family with Waardenburg syndrome type 1. Molecular and Cellular Probes 1997 June;: 233-236.
Wang C, Kim E, Attaie A, Smith TN, Wilcox ER, Lalwani AK. A PAX3 polymorphism (T315K) in a family exhibiting Waardenburg Syndrome type 2. Molecular and Cellular Probes 1998 February;: 55-57.
A five-generation family with late-onset progressive hereditary hearing impairment due to cochleosaccular degeneration. Audiology and Neuro-Otology 1997 May-June;: 139-154.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Attaie did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.